IN BRIEF: ValiRx shares up as subsidiary inks contract with US firm
ValiRx PLC - life sciences company focused on early-stage cancer therapeutics and women's health - Notes that its subsidiary Inaphaea BioLabs Limited wins a "revenue-bearing" contract for the provision of patient derived cell based services with a US-based biotech company. "The contract is a multi-stage project and encompasses analysis and provision of RNA data, acquired as part of the scientific package from Imagen Therapeutics, in addition to bespoke cell-based screening in the laboratory," ValiRx explains.
Read more